Fidelion Diagnostics Reports 392,329 Shares in BioNexus Gene Lab Corp

Fidelion Diagnostics filed a Form 3 disclosing direct ownership of 392,329 shares in BioNexus Gene Lab Corp, establishing a >5% stake without recent transaction activity.